Exane Derivatives’s Aramark ARMK Stock Holding History

Exane Derivatives’s Portfolio ARMK Stock Details ARMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.66K	Sell	120 -5,420	-98%	-$134K	﹤0.01%	420
2022 Q1	$150K	Sell	5,540 -3,339	-38%	-$87.1K	0.04%	402
2021 Q4	$236K	Sell	8,879 -15,525	-64%	-$406K	0.06%	307
2021 Q3	$579K	Buy	24,404 +1,140	+5%	+$28.2K	0.14%	158
2021 Q2	$589K	Buy	23,264 +23,243	+110,681%	+$638K	0.13%	152
2021 Q1	$567	Hold	21	–	–	﹤0.01%	786
2020 Q4	$577	Hold	21	–	–	﹤0.01%	726
2020 Q3	$397	Hold	21	–	–	﹤0.01%	693
2020 Q2	$339	Hold	21	–	–	﹤0.01%	637
2020 Q1	$300	Hold	21	–	–	﹤0.01%	638
2019 Q4	$685	Buy	+21	New	+$659	﹤0.01%	579
2017 Q3	–	Sell	-76,518	Closed	-$2.26M	–	574
2017 Q2	$2.26M	Buy	+76,518	New	+$2.1M	0.49%	49

Other funds holding ARMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Exane Derivatives's ARMK Position: Q2 2022 in Review

Exane Derivatives reduced its Aramark (ARMK) stake by 98% in Q2 2022, selling an estimated $134K and leaving 120 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

Exane Derivatives first reported a position in ARMK in Q2 2017 and has held it in 12 quarters since. The position peaked at $2.26M in Q2 2017. 305 funds tracked by Wall St. Rank hold ARMK as of Q2 2022.

Exane Derivatives held 120 shares of Aramark worth $2.66K as of Q2 2022.
Exane Derivatives sold 5,420 Aramark shares in Q2 2022, an estimated $134K.
Aramark made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #420 holding.
Exane Derivatives first reported a position in Aramark in Q2 2017 and has held it in 12 quarters since.
Exane Derivatives's Aramark position peaked at $2.26M in Q2 2017.
305 funds tracked by Wall St. Rank held Aramark as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.